Global consortium launches AI tools to accelerate Alzheimer’s research, treatments
Business Announcement
Updates every hour. Last Updated: 30-Oct-2026 07:15 ET (30-Oct-2026 11:15 GMT/UTC)
Over the past 20 years, microrobots have moved from scientific vision toward biomedical reality. A perspective article by Bradley J. Nelson from ETH Zurich reviews how microrobots, typically ranging from about a millimeter down to a few microns in size, are being developed as intelligent microscale machines for future precision medicine. Inspired by the motility and adaptability of microorganisms, these systems are designed to function in low-Reynolds-number environments, where viscous forces dominate and conventional macroscale actuation principles are no longer applicable. The article discusses the physical constraints of microscale locomotion, major propulsion mechanisms, fabrication and material strategies, embodied intelligence, biomedical applications, and remaining translational challenges. It further suggests that advances in biocompatible materials, high-resolution imaging, magnetic navigation, and AI-driven control may support the future transition of microrobots from laboratory prototypes to clinically relevant tools for next-generation precision medicine.
As cosmetic procedures become increasingly normalized worldwide, new research suggests that for some women, repeated treatments may become addiction-like rather than purely cosmetic. The study found that one in five women who had undergone cosmetic procedures met the threshold for moderate-to-severe risk of addictive cosmetic procedure use, with low body esteem and problematic social media use emerging as the strongest risk factors.
A new report in The Lancet Haematology, led by Cleveland Clinic hematologist Bethany Samuelson Bannow, M.D., outlines practical strategies to improve diagnosis, care and outcomes globally for women and girls with hematological conditions, such as bleeding disorders, heavy menstrual bleeding, postpartum hemorrhage, thrombosis and maternal hematologic complications.
The Commission on Global Female Health and Haematology highlights the need for earlier diagnosis, more consistent treatment, and stronger research and education for hematological conditions. Drawing on evidence from clinical care, research, public health and policy, the findings from the Lancet Haematology Commission were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris, France.